HILE

Zhitong · Sep 15, 2025 at 04:13 AM

HILE: The transaction price for the major asset purchase has been adjusted to 536 million yuan

Zhitong · Sep 10, 2025 at 02:45 AM

HILE: The registration application for Class III medical devices of the holding subsidiary has been accepted

Zhitong · Sep 1, 2025 at 04:03 AM

HILE: Bone repair material registration application accepted

Zhitong · Aug 27, 2025 at 05:21 AM

HILE released its semi-annual performance, with a net profit attributable to the parent company of 18.23 million yuan, a year-on-year increase of 20.56%

Zhitong · Jul 31, 2025 at 08:38 PM

The animal vaccine sector continues to rise, with Shen Lian Biomedical up over 10%

Zhitong · Jun 13, 2025 at 04:26 AM

HILE: Director and General Manager Han Benyi has not reduced his shareholding